Related Experiment Video
Updated: Jul 17, 2026
08:16
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
Interleukin-6 collection through long-term implanted microdialysis sampling probes in rat subcutaneous space
Xiangdan Wang1, Michelle R Lennartz, Daniel J Loegering
1Department of Chemistry & Chemical Biology and Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 110 Eighth Street, Troy, New York 12180-3590, USA.
Analytical Chemistry
|February 1, 2007
Summary
Microdialysis probe implantation for 3 or 7 days significantly reduces interleukin-6 (IL-6) recovery compared to acute probes. This reduction is primarily due to tissue encapsulation, not membrane biofouling, impacting immune response studies.
Area of Science:
- Immunology
- Biomedical Engineering
- Analytical Chemistry
Background:
- Microdialysis is a valuable technique for collecting signaling proteins like cytokines.
- Interleukin-6 (IL-6) plays a critical role in immune responses.
- Understanding factors affecting cytokine recovery in microdialysis is crucial for accurate immune monitoring.
Purpose of the Study:
- To investigate the impact of prolonged microdialysis probe implantation (3 and 7 days) on interleukin-6 (IL-6) recovery.
- To differentiate between tissue alterations and membrane biofouling as causes for reduced IL-6 recovery.
Main Methods:
- In vivo microdialysis probe implantation in animals for 0, 3, and 7 days.
- Administration of lipopolysaccharide (LPS) to stimulate IL-6 production.
- Comparison of IL-6 concentrations in dialysate from probes implanted for different durations.
- In vitro recovery experiments and scanning electron microscopy (SEM) for analysis.
Main Results:
- IL-6 recovery was reduced over 8-fold in probes implanted for 3 or 7 days compared to acute (day 0) probes.
- IL-6 concentrations were significantly lower (p<0.05) for 3-day (730 pg/mL) and 7-day (990 pg/mL) implants versus control (6440 pg/mL and 5520 pg/mL, respectively).
- SEM and in vitro data indicated tissue encapsulation, not membrane biofouling, as the primary cause of reduced recovery.
Conclusions:
- Prolonged microdialysis probe implantation leads to significant reductions in IL-6 recovery.
- Tissue encapsulation is the main factor responsible for decreased IL-6 levels in dialysate.
- Findings highlight the importance of considering implantation duration and tissue response in microdialysis studies of immune mediators.
